“Anti-obesity medications” or “medications to treat obesity” instead of “weight loss drugs” – why language matters – an official statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM)

Obesity is largely undertreated, in part because of the stigma surrounding the disease and its treatment. The use of the term “weight loss drugs” to refer to medications for the treatment of obesity may contribute to this stigma, leading to the idea that anyone who wants to lose weight could use the...

Descripción completa

Detalles Bibliográficos
Autores principales: Halpern, Bruno, Mancini, Marcio C., van de Sande-Lee, Simone, Miranda, Paulo Augusto Carvalho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2023
Materias:
Consensus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665066/
https://www.ncbi.nlm.nih.gov/pubmed/37585688
http://dx.doi.org/10.20945/2359-4292-2023-0174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665066/
https://www.ncbi.nlm.nih.gov/pubmed/37585688
http://dx.doi.org/10.20945/2359-4292-2023-0174

Ejemplares similares